Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Mus musculus | transient receptor potential cation channel, subfamily C, member 4 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | short transient receptor potential channel 6 | transient receptor potential cation channel, subfamily C, member 4 | 890 aa | 799 aa | 31.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0023 | 0 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0148 | 0.0573 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0771 | 0.0771 |
Schistosoma mansoni | transient receptor potential channel | 0.0117 | 0.655 | 0.655 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.2785 | 0.4252 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0113 | 0.6279 | 0.6279 |
Brugia malayi | Transient-receptor-potential like protein | 0.0044 | 0.1447 | 0.5197 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0117 | 0.655 | 0.655 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.2573 | 0.2573 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.1856 | 0.6666 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.2785 | 0.4252 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.1856 | 0.2834 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0148 | 0.0573 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.2785 | 0.2785 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.2573 | 0.2573 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0148 | 0.0225 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.2573 | 1 |
Echinococcus granulosus | TRP transient receptor potential channel | 0.0044 | 0.1447 | 0.1447 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.2573 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2785 | 0.2785 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.2573 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.2573 | 0.2573 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.2573 | 0.2573 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.3529 | 0.5387 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0078 | 0.3799 | 0.3799 |
Echinococcus multilocularis | TRP (transient receptor potential) channel | 0.0044 | 0.1447 | 0.1447 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0023 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.1177 | 0.1796 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.655 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0771 | 0.2768 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0148 | 1 |
Schistosoma mansoni | transient receptor potential channel | 0.0078 | 0.3799 | 0.3799 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0148 | 1 |
Echinococcus multilocularis | geminin | 0.0167 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2785 | 0.2785 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0117 | 0.655 | 0.655 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.2785 | 1 |
Schistosoma mansoni | transient receptor potential channel | 0.0078 | 0.3799 | 0.3799 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.2785 | 0.2785 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.2785 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0148 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0113 | 0.6279 | 0.6279 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.2573 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0148 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0148 | 0.053 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0078 | 0.3799 | 0.3799 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0078 | 0.3799 | 0.3799 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2785 | 0.2785 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1856 | 0.2834 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.1447 | 0.221 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2785 | 0.2785 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0771 | 0.1177 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0148 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0148 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.2785 | 0.4252 |
Brugia malayi | RNA binding protein | 0.0063 | 0.2785 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.2785 | 0.2785 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.2573 | 1 |
Echinococcus granulosus | transient receptor potential gamma protein | 0.0117 | 0.655 | 0.655 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.2573 | 1 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0078 | 0.3799 | 0.3799 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.1856 | 0.6666 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 0.596 uM | PUBCHEM_BIOASSAY: Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2237, AID2259] | ChEMBL. | No reference |
Potency (functional) | 0.0017 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.